Anna Cristina Garza‐Mayers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Cristina Garza‐Mayers has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Allison S. Dobry
University of California, San Francisco, Department of Dermatology, San Francisco, California
3 shared publications - Daniela Kroshinsky
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts
3 shared publications Elena B. Hawryluk
Department of Dermatology Massachusetts General Hospital Boston Massachusetts USA
3 shared publicationsJohn E. Harris
University of Massachusetts Medical Center Worcester Massachusetts USA
3 shared publications- Kristin A. Tissera
Duke University School of Medicine Durham North Carolina USA
3 shared publications - Lauren N. Ko
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
3 shared publications
Latest Publications
- 11 November 2026
- Published by Wiley in Pediatric Dermatology
A Cross‐Sectional Study of In‐Office Phototherapy for Pediatric Vitiligo in Washington State
Narrowband UVB phototherapy (nbUVB) is an important first‐line therapy in the management of vitiligo. We conducted a cross‐sectional study of offices of board‐certified dermatologists in Washington state to assess the availability of in‐office nbUVB for the treatment of vitiligo in children. Of 129 offices identified as offering phototherapy, 46/129 (35.7%) offered phototherapy for vitiligo, 42/46 (91.3%) treated children, and only 18/42 (42.9%) accepted Medicaid insurance, with counties with the highest rates of pediatric Medicaid coverage having no in‐office phototherapy options. This study highlights geographic and financial barriers to care in pediatric vitiligo and the need for a more comprehensive method for patients to identify in‐office phototherapy, and potentially highlights a role for home phototherapy units in pediatric care.
- 11 November 2026
- Published by Wiley in Pediatric Dermatology
A Cross‐Sectional Study of In‐Office Phototherapy for Pediatric Vitiligo in Washington State
Narrowband UVB phototherapy (nbUVB) is an important first‐line therapy in the management of vitiligo. We conducted a cross‐sectional study of offices of board‐certified dermatologists in Washington state to assess the availability of in‐office nbUVB for the treatment of vitiligo in children. Of 129 offices identified as offering phototherapy, 46/129 (35.7%) offered phototherapy for vitiligo, 42/46 (91.3%) treated children, and only 18/42 (42.9%) accepted Medicaid insurance, with counties with the highest rates of pediatric Medicaid coverage having no in‐office phototherapy options. This study highlights geographic and financial barriers to care in pediatric vitiligo and the need for a more comprehensive method for patients to identify in‐office phototherapy, and potentially highlights a role for home phototherapy units in pediatric care.
- 6 July 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Management patterns and repigmentation outcomes in paediatric segmental versus nonsegmental vitiligo: a single-centre retrospective study 2015–2024
Segmental vitiligo (SV) is traditionally perceived as more treatment-resistant than nonsegmental vitiligo (NSV) because it tends to rapidly stabilize after a brief period of onset and progression. In this tertiary paediatric cohort, we found no significant differences in the occurrence of any repigmentation between SV and NSV. Our findings support the potential efficacy of treatment for all types of vitiligo.
- 6 July 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Management patterns and repigmentation outcomes in paediatric segmental versus nonsegmental vitiligo: a single-centre retrospective study 2015–2024
Segmental vitiligo (SV) is traditionally perceived as more treatment-resistant than nonsegmental vitiligo (NSV) because it tends to rapidly stabilize after a brief period of onset and progression. In this tertiary paediatric cohort, we found no significant differences in the occurrence of any repigmentation between SV and NSV. Our findings support the potential efficacy of treatment for all types of vitiligo.
- 8 October 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (2) , 415-420
Continuous Subcutaneous Insulin Infusion ( CSII )‐Associated Granulomatous Suppurative Reaction in Four Children With Type 1 Diabetes
With the increasing use of continuous glucose monitors and continuous subcutaneous insulin infusion (CSII) devices in pediatric patients with type 1 diabetes (T1DM), dermatologic complications are being reported more frequently. We describe four children with T1DM who developed persistent erythematous nodules with suppurative granulomatous inflammation at prior CSII injection sites. Treatment responses varied: one child improved after transitioning to subcutaneous insulin injections, another with oral dapsone, a third after switching CSII devices and limiting placement to the abdomen, and a fourth with topical corticosteroids and antibiotic ointment. This rare complication appears unrelated to specific device models or insulin types, highlighting the need for further studies to identify risk factors and guide optimal management.
- 8 October 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (2) , 415-420
Continuous Subcutaneous Insulin Infusion ( CSII )‐Associated Granulomatous Suppurative Reaction in Four Children With Type 1 Diabetes
With the increasing use of continuous glucose monitors and continuous subcutaneous insulin infusion (CSII) devices in pediatric patients with type 1 diabetes (T1DM), dermatologic complications are being reported more frequently. We describe four children with T1DM who developed persistent erythematous nodules with suppurative granulomatous inflammation at prior CSII injection sites. Treatment responses varied: one child improved after transitioning to subcutaneous insulin injections, another with oral dapsone, a third after switching CSII devices and limiting placement to the abdomen, and a fourth with topical corticosteroids and antibiotic ointment. This rare complication appears unrelated to specific device models or insulin types, highlighting the need for further studies to identify risk factors and guide optimal management.
- 18 March 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (3) , 517-522
Survey of Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo
This study sought to evaluate narrowband UVB phototherapy in pediatric vitiligo through an online patient and caregiver survey to better understand patient experiences and barriers to care in this population. In a survey of 111 respondents, 51.4% were offered nbUVB and 45.1% utilized nbUVB for treatment of vitiligo before age 18 years. The primary reasons for not pursuing nbUVB included it not being offered (36.1%), difficulty attending appointments (11.5%), and satisfaction with the current skin condition (11.5%). Our results suggest nbUVB may be underutilized in pediatric vitiligo; addressing obstacles to access is crucial for improving treatment outcomes and quality of life.
- 18 March 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (3) , 517-522
Survey of Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo
This study sought to evaluate narrowband UVB phototherapy in pediatric vitiligo through an online patient and caregiver survey to better understand patient experiences and barriers to care in this population. In a survey of 111 respondents, 51.4% were offered nbUVB and 45.1% utilized nbUVB for treatment of vitiligo before age 18 years. The primary reasons for not pursuing nbUVB included it not being offered (36.1%), difficulty attending appointments (11.5%), and satisfaction with the current skin condition (11.5%). Our results suggest nbUVB may be underutilized in pediatric vitiligo; addressing obstacles to access is crucial for improving treatment outcomes and quality of life.
- 3 March 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (5) , 1016-1019
Investigation of Hearing Loss in Pediatric Vitiligo
Prior studies have investigated the association between vitiligo and sensorineural hearing loss in adults; based on this potential association, we aimed to investigate the association of vitiligo with hearing loss in children. This was conducted as an IRB‐approved multi‐center retrospective analysis of pure tone audiometry and otoacoustic emission testing of 158 pediatric vitiligo patients compared to 316 age‐ and sex‐matched healthy subjects at three institutions between 2000 and 2023. Our results demonstrate no significant increased incidence of hearing deficit in pediatric vitiligo patients, though both vitiligo and control populations demonstrated increased incidence of hearing loss. Further studies are required to determine whether pediatric vitiligo patients may benefit from early and/or regular screening examination and intervention, as hearing is critical for speech, language, and social development.
- 3 March 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (5) , 1016-1019
Investigation of Hearing Loss in Pediatric Vitiligo
Prior studies have investigated the association between vitiligo and sensorineural hearing loss in adults; based on this potential association, we aimed to investigate the association of vitiligo with hearing loss in children. This was conducted as an IRB‐approved multi‐center retrospective analysis of pure tone audiometry and otoacoustic emission testing of 158 pediatric vitiligo patients compared to 316 age‐ and sex‐matched healthy subjects at three institutions between 2000 and 2023. Our results demonstrate no significant increased incidence of hearing deficit in pediatric vitiligo patients, though both vitiligo and control populations demonstrated increased incidence of hearing loss. Further studies are required to determine whether pediatric vitiligo patients may benefit from early and/or regular screening examination and intervention, as hearing is critical for speech, language, and social development.
- 20 February 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (2) , 318-321
No Association of Pediatric Vitiligo With Visual Acuity Deficits
Vitiligo is characterized by the autoimmune destruction of melanocytes, which most visibly affect skin pigmentation, but are also present in the choroid and retinal pigmented epithelium of the eye raising the possibility of underappreciated vision loss in affected populations. To inform whether this vulnerable population should be more rigorously screened and offered early intervention, we performed a multi‐center retrospective analysis of optotype recognition of 248 pediatric vitiligo patients compared with 496 age‐ and sex‐matched healthy subjects between 2000 and 2023; we found a significant difference in the risk of visual acuity deficits in patients as compared with healthy controls ( p = 0.0476), although this association was lost when controlling for family history and genetic diagnoses associated with visual acuity deficits or vision loss. These results extend prior studies in adult populations and are consistent with current guidelines that do not recommend routine vision screening the pediatric vitiligo population, although further studies are warranted to determine if there are more subtle changes in vision and eye function.
- 20 February 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (2) , 318-321
No Association of Pediatric Vitiligo With Visual Acuity Deficits
Vitiligo is characterized by the autoimmune destruction of melanocytes, which most visibly affect skin pigmentation, but are also present in the choroid and retinal pigmented epithelium of the eye raising the possibility of underappreciated vision loss in affected populations. To inform whether this vulnerable population should be more rigorously screened and offered early intervention, we performed a multi‐center retrospective analysis of optotype recognition of 248 pediatric vitiligo patients compared with 496 age‐ and sex‐matched healthy subjects between 2000 and 2023; we found a significant difference in the risk of visual acuity deficits in patients as compared with healthy controls ( p = 0.0476), although this association was lost when controlling for family history and genetic diagnoses associated with visual acuity deficits or vision loss. These results extend prior studies in adult populations and are consistent with current guidelines that do not recommend routine vision screening the pediatric vitiligo population, although further studies are warranted to determine if there are more subtle changes in vision and eye function.
- 5 September 2022
- Published by Wiley in Pediatric Dermatology
- Vol. 39 (6) , 1005-1006
Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser
Dominant dystrophic epidermolysis bullosa (DDEB), an inherited disorder due to type VII collagen mutations, is characterized by blisters and erosions that heal with scarring, atrophy, and milia. There is no established role for laser in the management of patients with DDEB. Pulsed dye laser (PDL) is most often used to target vascular skin lesions. We describe a patient with DDEB with marked improvement in erythema as well as fewer and less symptomatic episodes of blistering following treatment with PDL.
- 5 September 2022
- Published by Wiley in Pediatric Dermatology
- Vol. 39 (6) , 1005-1006
Improved erythema and decreased blister formation in dominant dystrophic epidermolysis bullosa following treatment with pulsed dye laser
Dominant dystrophic epidermolysis bullosa (DDEB), an inherited disorder due to type VII collagen mutations, is characterized by blisters and erosions that heal with scarring, atrophy, and milia. There is no established role for laser in the management of patients with DDEB. Pulsed dye laser (PDL) is most often used to target vascular skin lesions. We describe a patient with DDEB with marked improvement in erythema as well as fewer and less symptomatic episodes of blistering following treatment with PDL.
- Open Access
- 8 June 2021
- Published by Elsevier in JID Innovations
- Vol. 1 (3) , 100032
Diffuse Reflectance Spectroscopy with Infrared Thermography for Accurate Prediction of Cellulitis
- 8 June 2021
- Published by Elsevier in JID Innovations
- Vol. 1 (3) , 100032
Open AccessDiffuse Reflectance Spectroscopy with Infrared Thermography for Accurate Prediction of Cellulitis
- Open Access
- 1 July 2018
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (7) , 994-996
Clinical Usefulness of Imaging and Blood Cultures in Cellulitis Evaluation
Cellulitis is a commonly occurring acute bacterial skin infection of the dermis and subcutaneous skin. In the United States, there are approximately 14.5 million cases of cellulitis annually, resulting in 650 000 hospital admissions.1 The Infectious Disease Society of America (IDSA) released evidence-based guidelines that advise against imaging except in patients with cellulitis and febrile neutropenia, and against blood cultures except in patients who were highly immunocompromised, exhibiting systemic toxic effects, or who had sustained animal bites.2 This study evaluates the clinical usefulness and cost of blood cultures and imaging in patients with presumed cellulitis.
- 1 July 2018
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (7) , 994-996
Open AccessClinical Usefulness of Imaging and Blood Cultures in Cellulitis Evaluation
Cellulitis is a commonly occurring acute bacterial skin infection of the dermis and subcutaneous skin. In the United States, there are approximately 14.5 million cases of cellulitis annually, resulting in 650 000 hospital admissions.1 The Infectious Disease Society of America (IDSA) released evidence-based guidelines that advise against imaging except in patients with cellulitis and febrile neutropenia, and against blood cultures except in patients who were highly immunocompromised, exhibiting systemic toxic effects, or who had sustained animal bites.2 This study evaluates the clinical usefulness and cost of blood cultures and imaging in patients with presumed cellulitis.
- Open Access
- 1 May 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (5) , S54
319 Skin surface temperature detection with thermal imaging camera aids in cellulitis diagnosis
- 1 May 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (5) , S54
Open Access319 Skin surface temperature detection with thermal imaging camera aids in cellulitis diagnosis